Cargando…

Molecular Alterations Associated with Breast Cancer Mortality

BACKGROUND: Breast cancer is a heterogeneous disease and patients with similar pathologies and treatments may have different clinical outcomes. Identification of molecular alterations associated with disease outcome may improve risk assessment and treatments for aggressive breast cancer. METHODS: Al...

Descripción completa

Detalles Bibliográficos
Autores principales:	Voeghtly, Laura M., Mamula, Kim, Campbell, J. Leigh, Shriver, Craig D., Ellsworth, Rachel E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3464216/ https://www.ncbi.nlm.nih.gov/pubmed/23056464 http://dx.doi.org/10.1371/journal.pone.0046814

Ejemplares similares

Outcome disparities in African American women with triple negative breast cancer: a comparison of epidemiological and molecular factors between African American and Caucasian women with triple negative breast cancer
por: Sturtz, Lori A, et al.
Publicado: (2014)

Molecular Heterogeneity in Primary Breast Carcinomas and Axillary Lymph Node Metastases Assessed by Genomic Fingerprinting Analysis
por: Ellsworth, Rachel E, et al.
Publicado: (2015)

Breast Cancer in the Personal Genomics Era
por: Ellsworth, Rachel E., et al.
Publicado: (2010)

Molecular signatures of lymph node status by intrinsic subtype: gene expression analysis of primary breast tumors from patients with and without metastatic lymph nodes
por: Shriver, Craig D, et al.
Publicado: (2014)

Effect of obesity on molecular characteristics of invasive breast tumors: gene expression analysis in a large cohort of female patients
por: Toro, Allyson L., et al.
Publicado: (2016)

Relationships between the ABO blood group SNP rs505922 and breast cancer phenotypes: a genotype-phenotype correlation study
por: Rummel, Seth, et al.
Publicado: (2012)

Genomic Heterogeneity of Breast Tumor Pathogenesis
por: Ellsworth, Rachel E., et al.
Publicado: (2009)

PSPHL and breast cancer in African American women: causative gene or population stratification?
por: Rummel, Seth, et al.
Publicado: (2014)

Survival Disparities in US Black Compared to White Women with Hormone Receptor Positive-HER2 Negative Breast Cancer
por: Lovejoy, Leann A., et al.
Publicado: (2023)

Relationship between Cigarette Smoking and Cancer Characteristics and Survival among Breast Cancer Patients
por: Darmon, Sarah, et al.
Publicado: (2022)

Should Genetic Testing for Cancer Predisposition Be Standard-of-Care for Women with Invasive Breast Cancer? The Murtha Cancer Center Experience
por: Rummel, Seth K., et al.
Publicado: (2020)

Sequence-based detection of mutations in cadherin 1 to determine the prevalence of germline mutations in patients with invasive lobular carcinoma of the breast
por: Valente, Allyson L, et al.
Publicado: (2014)

Tumour location within the breast: Does tumour site have prognostic ability?
por: Rummel, Seth, et al.
Publicado: (2015)

Nondisparate Survival of Non-Hispanic Black Women With Breast Cancer Despite Less Favorable Pathology: Effect of Access to and Provision of Care Within a Military Health Care System
por: Darmon, Sarah, et al.
Publicado: (2023)

Differential Gene Expression in Primary Breast Tumors Associated with Lymph Node Metastasis
por: Ellsworth, Rachel E., et al.
Publicado: (2011)

Cancer Previvors in an Active Duty Service Women Population: An Opportunity for Prevention and Increased Force Readiness
por: Lovejoy, Leann A, et al.
Publicado: (2021)

Heritability of Low ER Staining/HER2-Breast Tumors: Are We Missing an Opportunity for Germline Testing?
por: Lovejoy, Leann A., et al.
Publicado: (2020)

Management of Incidental Findings in the Era of Next-generation Sequencing
por: Blackburn, Heather L., et al.
Publicado: (2015)

Single-cell sequencing and tumorigenesis: improved understanding of tumor evolution and metastasis
por: Ellsworth, Darrell L., et al.
Publicado: (2017)

FH535 Inhibited Migration and Growth of Breast Cancer Cells
por: Iida, Joji, et al.
Publicado: (2012)

Eligibility, uptake and response to germline genetic testing in women with DCIS
por: Turza, Lauren, et al.
Publicado: (2022)

Amplification of HER2 is a marker for global genomic instability
por: Ellsworth, Rachel E, et al.
Publicado: (2008)

A Review of the Hereditary Component of Triple Negative Breast Cancer: High- and Moderate-Penetrance Breast Cancer Genes, Low-Penetrance Loci, and the Role of Nontraditional Genetic Elements
por: Ellsworth, Darrell L., et al.
Publicado: (2019)

Leukocyte DNA as Surrogate for the Evaluation of Imprinted Loci Methylation in Mammary Tissue DNA
por: Barault, Ludovic, et al.
Publicado: (2013)

Assessing the quality of RNA isolated from human breast tissue after ambient room temperature exposure
por: Somiari, Stella B., et al.
Publicado: (2022)

Positive Association of Fibroadenomatoid Change with HER2-Negative Invasive Breast Cancer: A Co-Occurrence Study
por: Chen, Yaqin, et al.
Publicado: (2015)

The Year in Immunology 1988. Cellular, Molecular and Clinical Aspects
por: Mamula, Mark J.
Publicado: (1989)

Breast Cancer Biology and Ethnic Disparities in Breast Cancer Mortality in New Zealand: A Cohort Study
por: Seneviratne, Sanjeewa, et al.
Publicado: (2015)

Hyperglycemia Associated Metabolic and Molecular Alterations in Cancer Risk, Progression, Treatment, and Mortality
por: Ramteke, Pranay, et al.
Publicado: (2019)

Effect of Differences in Access to Screening, Healthcare, and Treatment on Cancer Disparities
por: Ellsworth, Rachel E.
Publicado: (2022)

Recurrent copy number alterations in young women with breast cancer
por: Chi, Chen, et al.
Publicado: (2018)

Breast Axillary Lymph Node Metastasis
por: Cavalli, Luciane R., et al.
Publicado: (2011)

Functional role of vitronectin in breast cancer
por: Bera, Alakesh, et al.
Publicado: (2020)

Development of a Bayesian Classifier for Breast Cancer Risk Stratification: A Feasibility Study
por: Stojadinovic, Alexander, et al.
Publicado: (2010)

Altered Circadian Rhythms and Breast Cancer: From the Human to the Molecular Level
por: Lin, Hui-Hsien, et al.
Publicado: (2018)

Loss of giant obscurins alters breast epithelial cell mechanosensing of matrix stiffness
por: Stroka, Kimberly M., et al.
Publicado: (2016)

Molecular alterations associated with prostate cancer
por: Garcia Perdomo, Herney Andres, et al.
Publicado: (2018)

The DNA damage repair landscape in Black women with breast cancer
por: Mazumder, Aloran, et al.
Publicado: (2022)

GRP78 Level Is Altered in the Brain, but Not in Plasma or Cerebrospinal Fluid in Parkinson’s Disease Patients
por: Baek, Jean-Ha, et al.
Publicado: (2019)

The utility of conventional and molecular pathology in managing breast cancer
por: Allred, D Craig
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_36pml2bpr9v60jnlbutua000fn